Zakrzewski J, Bechert T, Guggenbichler J P
Universitätsklinik für Kinder und Jugendliche, Erlangen, Germany.
Infection. 1998 Mar-Apr;26(2):116-9. doi: 10.1007/BF02767773.
Thirty-eight clinical isolates of Haemophilus influenzae and ten clinical isolates of Streptococcus pneumoniae were examined for IgA1 protease production. A suspension of surface material of each individual strain was incubated with human secretory IgA; IgA1 cleavage products were detected by SDS-PAGE and immunoblotting. The high incidence of IgA1 protease-positive strains (68.4% of the examined H. influenzae and 100% of the examined S. pneumoniae strains) confirms that IgA1 protease activity is a frequent characteristic of these two species. Yet the presence of this enzyme is, if at all, only a minor decisive factor for the induction of symptomatic infections of the upper respiratory tract by IgA1 protease-positive bacteria.
对38株流感嗜血杆菌临床分离株和10株肺炎链球菌临床分离株进行了IgA1蛋白酶产生情况检测。将各菌株的表面物质悬液与人分泌型IgA一起孵育;通过SDS-PAGE和免疫印迹法检测IgA1裂解产物。IgA1蛋白酶阳性菌株的高发生率(检测的流感嗜血杆菌中有68.4%,检测的肺炎链球菌菌株中有100%)证实IgA1蛋白酶活性是这两个菌种的常见特征。然而,这种酶的存在即便对IgA1蛋白酶阳性细菌引起上呼吸道症状性感染而言,也只是一个次要的决定性因素。